Walter A Hall

Title: Walter A. Hall: Innovator in Medical Research

Introduction

Walter A. Hall is a prominent inventor based in Minneapolis, MN (US). He has made significant contributions to the field of medical research, particularly in the development of innovative treatments for serious health conditions. With a total of 2 patents, Hall's work focuses on advancing therapeutic methods that can improve patient outcomes.

Latest Patents

One of Hall's latest patents is the DTAT fusion toxin. This invention provides fusion toxins that contain one or more regions of diphtheria toxin and a portion of urokinase-type plasminogen activator. It also includes the nucleic acids that encode the fusion toxins and methods of using them. Another significant patent is related to antisense oligonucleotides and methods for treating primary brain cancer. This invention offers compositions and methods that include at least one antisense oligonucleotide that inhibits the proliferation of primary brain cancer cells. The oligonucleotides are designed to be complementary to and hybridize with mRNA encoding c-myb, providing a targeted approach to treatment.

Career Highlights

Walter A. Hall is affiliated with the University of Minnesota, where he continues to engage in groundbreaking research. His work has the potential to change the landscape of treatment for various medical conditions, particularly in oncology.

Collaborations

Hall has collaborated with notable colleagues, including Walter C. Low and Eric P. Flores. These partnerships have fostered an environment of innovation and have contributed to the advancement of their shared research goals.

Conclusion

Walter A. Hall is a distinguished inventor whose contributions to medical research are noteworthy. His patents reflect a commitment to developing effective treatments for critical health issues. Through his work at the University of Minnesota, he continues to push the boundaries of medical science.